Suppression of vascular endothelial growth factor via inactivation of eukaryotic elongation factor 2 by alkaloids in coptidis rhizome in hepatocellular carcinoma

Integrative Cancer Therapies

Volumn 13, Issue 5, 2014, Pages 425-434

  Tan, Hor Yue ^a   Wang, Ning ^a   Tsao, Sai Wah ^b   Zhang, Zhangjin ^a   Feng, Yibin ^a  

^a THE UNIVERSITY OF HONG KONG   (Hong Kong)

^b UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

Coptidis rhizome aqueous extract; eukaryotic elongation factor 2; hepatocellular carcinoma; nascent protein synthesis; vascular endothelial growth factor

Indexed keywords

ALKALOID DERIVATIVE; BERBERINE; COPTIS RHIZOME EXTRACT; ELONGATION FACTOR 2; JATRORRHIZINE; MAGNOFLORINE; MESSENGER RNA; ORGANOCHLORINE PESTICIDE; PALMATINE; VASCULOTROPIN; ALKALOID; ANGIOGENESIS INHIBITOR; HERBACEOUS AGENT; VASCULOTROPIN A;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIANGIOGENIC ACTIVITY; ARTICLE; CANCER MODEL; CONTROLLED STUDY; COPTIS; ENZYME LINKED IMMUNOSORBENT ASSAY; GENE EXPRESSION; HEPG2 CELL LINE; HUMAN; HUMAN CELL; IN VIVO STUDY; LIVER CELL CARCINOMA; MOUSE; NONHUMAN; PHYTOCHEMISTRY; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; PROTEIN SECRETION; PROTEIN SYNTHESIS; QUANTITATIVE ANALYSIS; REAL TIME POLYMERASE CHAIN REACTION; TUMOR VOLUME; TUMOR XENOGRAFT; ANIMAL; ANTAGONISTS AND INHIBITORS; CARCINOMA, HEPATOCELLULAR; CHEMISTRY; DRUG EFFECTS; DRUG SCREENING; GENE EXPRESSION REGULATION; GENETICS; ISOLATION AND PURIFICATION; LIVER NEOPLASMS; NEOVASCULARIZATION, PATHOLOGIC; NUDE MOUSE; PATHOLOGY; TUMOR CELL LINE;

ALKALOIDS; ANGIOGENESIS INHIBITORS; ANIMALS; CARCINOMA, HEPATOCELLULAR; CELL LINE, TUMOR; DRUGS, CHINESE HERBAL; ENZYME-LINKED IMMUNOSORBENT ASSAY; GENE EXPRESSION REGULATION, NEOPLASTIC; HEP G2 CELLS; HUMANS; LIVER NEOPLASMS; MICE; MICE, NUDE; NEOVASCULARIZATION, PATHOLOGIC; PEPTIDE ELONGATION FACTOR 2; REAL-TIME POLYMERASE CHAIN REACTION; VASCULAR ENDOTHELIAL GROWTH FACTOR A; XENOGRAFT MODEL ANTITUMOR ASSAYS;

EID: 84906053371     PISSN: 15347354     EISSN: 1552695X     Source Type: Journal    
DOI: 10.1177/1534735413513635     Document Type: Article

References (38)

1. World Health Organization. GLOBOCAN 2008: liver cancer incidence, mortality and prevalence worldwide in 2008. http://globocan.iarc.fr/factsheet. asp. Published June2010. Accessed April 10, 2013.
2. American Cancer Society. Survival rates for liver cancer. http://www.cancer.org/cancer/livercancer/detailedguide/liver-cancer-survival- rates. Published January2013. Accessed April 10, 2013.
3. Farazi PA, DePinho RA. Hepatocellular carcinoma pathogenesis: from genes to environment. Nat Rev Cancer. 2006 ; 6: 674-687
4. Tang ZY. Hepatocellular carcinoma: cause, treatment and metastasis. World J Gastroenterol. 2001 ; 7: 445-454
5. Macchiarini P, Fontanini G, Hardin MJ, Squartini F, Angeletti CA. Relation of neovascularisation to metastasis of non-small-cell lung cancer. Lancet. 1992 ; 340: 145-146
6. Weidner N, Semple JP, Welch WR, Folkman J. Tumour angiogenesis and metastasis: correlation in invasive breast carcinoma. N Engl J Med. 1991 ; 324: 1-8
7. Pang R, Poon RTP. Angiogenesis and antiangiogenic therapy in hepatocellular carcinoma. Cancer Lett. 2006 ; 242: 151-167
8. Chinese Herbals (Zhong Hua Ben Cao). Shanghai, China: Shanghai Science and Technology Press ; 1999 :
9. Tang J, Feng Y, Tsao S, Wang N, Curtain R, Wang Y. Berberine and Coptidis rhizoma as novel antineoplastic agents: a review of traditional use and biomedical investigations. J Ethnopharmacol. 2009 ; 126: 5-17
10. Wan X, Chen X, Liu L, et al. Berberine ameliorates chronic kidney injury caused by atherosclerotic renovascular disease through the suppression of NFΰB signalling pathway in rats. PLoS One. 2013 ; 8: e59794
11. Kuo CL, Chi CW, Liu TY. The anti-inflammatory potential of berberine in vitro and in vivo. Cancer Lett. 2004 ; 203: 127-137
12. Tsang CM, Lau EP, Di K, et al. Berberine inhibits Rho GTPases and cell migration at low doses but induces G2 arrest and apoptosis at high doses in human cancer cells. Int J Mol Med. 2009 ; 24: 131-138
13. Wang N, Feng Y, Zhu M, Tsang C, Man K, Tong Y. Berberine induces autophagic cell death and mitochondrial apoptosis in liver cancer cells: the cellular mechanism. J Cell Biochem. 2010 ; 111: 1426-1436
14. Chidambara MKN, Jayaprakasha GK, Patil BS. The natural alkaloid berberine targets multiple pathways to induce cell death in cultured human colon cancer cells. Eur J Pharmacol. 2012 ; 688: 14-21
15. Feng Y, Siu KY, Ye X, et al. Hepatoprotective effects of berberine on carbon tetrachloride-induced acute hepatotoxicity in rats. Chinese Med. 2010 ; 5: 1-6
16. Gu JJ, Gao FY, Zhao TY. A preliminary investigation of the mechanisms underlying the effect of berberine in preventing high-fat diet-induced insulin resistance in rats. J Physiol Pharmacol. 2012 ; 63: 505-513
17. Jie S, Li H, Tian Y, et al. Berberine inhibits angiogenic potential of Hep G2 cell line through VEGF down-regulation in vitro. J. Gastroenterol Hepatol. 2011 ; 26: 179-185
18. Gao JL, Shi JM, Lee SM, Zhang QW, Wang YT. Angiogenic pathway inhibition of Corydalis yanhusuo and berberine in human umbilical vein endothelial cells. Oncol Res. 2009 ; 17: 519-526
19. Lin S, Tsai SC, Lee CC, Wang BW, Liou JY, Shyu KG. Berberine inhibits HIF-1alpha expression via enhanced proteolysis. Mol Pharmacol. 2004 ; 66: 612-619
20. Kim YJ, Kang SA, Hong MS, et al. Coptidis rhizoma induces apoptosis in human colorectal cancer cells SNU-C4. Am J Chin Med. 2004 ; 32: 873-882
21. Lee HJ, Son DH, Lee SK, et al. Extract of Coptidis rhizoma induces cytochrome-c dependent apoptosis in immortalized and malignant human oral keratinocytes. Phytother Res. 2006 ; 20: 773-779
22. Kang JX, Liu J, Wang J, He C, Li FP. The extract of huanglian, a medicinal herb, induces cell growth arrest and apoptosis by upregulation of interferon-beta and TNF-alpha in human breast cancer cells. Carcinogenesis. 2005 ; 26: 1934-1939
23. Wang N, Feng Y, Lau EP, et al. F-actin reorganization and inactivation of rho signaling pathway involved in the inhibitory effect of Coptidis rhizoma on hepatoma cell migration. Integr Cancer Ther. 2010 ; 9: 354-364
24. Zhu M, Wang N, Tsao S, et al. Up-regulation of microRNAs, miR21 and miR23a in human liver cancer cells treated with Coptidis rhizoma aqueous extract. Exp Ther Med. 2011 ; 2: 27-32
25. Feng Y, Wang N, Ye X, et al. Hepatoprotective effect and its possible mechanism of Coptidis rhizoma aqueous extract on carbon tetrachloride-induced chronic liver hepatotoxicity in rats. J Ethnopharmacol. 2011 ; 138: 683-690
26. Wang N, Feng Y, Cheung F, et al. A comparative study on the hepatoprotective action of bear bile and Coptidis rhizoma aqueous extract on experimental liver fibrosis in rat. BMC Complement Altern Med. 2012 ; 12: 239
27. Mosmann T. Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicty assays. J Immunol Methods. 1983 ; 65: 55-63
28. Liu LX, Lu H, Luo Y, et al. Stabilization of vascular endothelial growth factor mRNA by hypoxia-inducible factor 1. Biochem Biophys Res Commun. 2002 ; 291: 908-914
29. Ma Y, Hendershot LM. The role of the unfolded protein response in tumour development: friend or foe?. Nat Rev Cancer. 2004 ; 4: 966-977
30. Browne GJ, Proud CG. Regulation of peptide-chain elongation in mammalian cells. Eur J Biochem. 2002 ; 269: 5360-5368
31. Nakamura J, Aoyagi S, Nanchi I, et al. Overexpression of eukaryotic elongation factor eEF2 in gastrointestinal cancers and its involvement in G2/M progression in the cell cycle. Int J Oncol. 2009 ; 34: 1181-1189
32. Chen CY, Fang HY, Chiou SH, et al. Sumoylation of eukaryotic elongation factor 2 is vital for protein stability and anti-apoptotic activity in lung adenocarcinoma cells. Cancer Sci. 2011 ; 102: 1582-1589
33. Bilanges B, Stokoe D. Mechanisms of translational deregulation in human tumors and therapeutic intervention strategies. Oncogene. 2007 ; 26: 41
34. White SJ, Kasman LM, Kelly MM, et al. Doxorubicin generates a proapoptotic phenotype by phosphorylation of elongation factor 2. Free Radic Biol Med. 2007 ; 43: 1313-1321
35. Romero-Ruiz A, Bautista L, Navarro V, et al. Prolyl hydroxylase-dependent modulation of eukaryotic elongation factor 2 activities and protein translation under acute hypoxia. J Biol Chem. 2012 ; 287: 9651-9658
36. Wouters BG, van den Beucken T, Magagnin MG, Koritzinsky M, Fels D, Koumenis C. Control of the hypoxic response through regulation of mRNA translation. Semin Cell Dev Biol. 2005 ; 16: 487-501
37. Videira PA, Piteira AR, Cabral MG, et al. Effects of bevacizumab on autocrine VEGF stimulation in bladder cancer cell lines. Urol Int. 2011 ; 86: 95-101
38. Yamagishi N, Teshima-Kondo S, Masuda K, et al. Chronic inhibition of tumor cell-derived VEGF enhances the malignant phenotype of colorectal cancer cells. BMC Cancer. 2013 ; 13: 229